Yi-Li Jiang

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease

T. Sui, Mingfeng Zhao, Wenyi Lu, 2021, Cancer Immunology, Immunotherapy.

HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation

Xiaoyuan He, Lin Cheng, Mingfeng Zhao, 2019, Leukemia.

Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma

Z. Qian, J. Mu, Q. Deng, 2021, Cancer science.

Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation

E. Jiang, Wenyi Lu, Mingzhe Han, 2019, Leukemia & lymphoma.

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients

Wenyi Lu, Xia Xiao, J. Mu, 2022, Cell transplantation.

Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation

Yan-yu Jiang, Q. Deng, Qing Li, 2020, OncoTargets and therapy.